Helen Scarnati

Genotypic Correlates of Phenotypic Resistance to Efavirenz in Virus Isolates from Patients Failing Nonnucleoside Reverse Transcriptase Inhibitor Therapy

Lee T. Bacheler, Susan Jeffrey, George J. Hanna et al. · Journal of Virology · 2001 · 240 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Biochemical and Genetic Characterizations of a Novel Human Immunodeficiency Virus Type 1 Inhibitor That Blocks gp120-CD4 Interactions

Qi Guo, Hsu‐Tso Ho, Ira B. Dicker et al. · Journal of Virology · 2003 · 168 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Limited Sequence Diversity of the HIV Type 1 Protease Gene from Clinical Isolates and <i>in Vitro</i> Susceptibility to HIV Protease Inhibitors

Dean L. Winslow, Sylvia Stack, Robert J. King et al. · AIDS Research and Human Retroviruses · 1995 · 56 citations

Life Sciences, Infectious Diseases, Molecular Biology +15

Selection conditions affect the evolution of specific mutations in the reverse transcriptase gene associated with resistance to DMP 266

Dean L. Winslow, Sena Garber, Carol Reid et al. · AIDS · 1996 · 54 citations

Life Sciences, Microbiology, Molecular Genetics +17

In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitor

Michaël Otto, Carol Reid, Sena Garber et al. · Antimicrobial Agents and Chemotherapy · 1993 · 32 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13